GE HealthCare Technologies Inc
Company Profile
Business description
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Contact
500 West Monroe Street
ChicagoIL60661
USAT: +1 833 735-1139
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2025
Employees
53,000
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
stocks
New production imminent for undervalued ASX gas play
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,290.60 | 6.80 | 0.07% |
CAC 40 | 8,174.20 | 14.39 | -0.18% |
DAX 40 | 23,830.99 | 441.20 | -1.82% |
Dow JONES (US) | 46,190.61 | 238.37 | 0.52% |
FTSE 100 | 9,354.57 | 81.52 | -0.86% |
HKSE | 25,766.24 | 519.14 | 2.06% |
NASDAQ | 22,679.97 | 117.44 | 0.52% |
Nikkei 225 | 48,846.69 | 1,264.54 | 2.66% |
NZX 50 Index | 13,301.09 | 11.88 | 0.09% |
S&P 500 | 6,664.01 | 34.94 | 0.53% |
S&P/ASX 200 | 8,994.30 | 6.10 | 0.07% |
SSE Composite Index | 3,862.60 | 22.84 | 0.59% |